共 199 条
[1]
Asrani SK(2019)Burden of liver diseases in the world J Hepatol 70 151-171
[2]
Devarbhavi H(2021)Molecular and cellular mechanisms of liver fibrosis and its regression Nat Rev Gastroenterol Hepatol 18 151-166
[3]
Eaton J(2006)Clinical utility of biomarkers of liver fibrosis Gastroenterol Hepatol (N Y) 2 48-57
[4]
Kamath PS(2017)Development of a simple noninvasive model to predict significant fibrosis in patients with chronic hepatitis B: combination of ultrasound elastography, serum biomarkers, and individual characteristics Clin Transl Gastroenterol 8 e84-33
[5]
Kisseleva T(2019)Molecular imaging of fibrosis: recent advances and future directions J Clin Invest 129 24-696
[6]
Brenner D(2015)3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model J Hepatol 63 689-411
[7]
Patel K(2019)Early detection and staging of chronic liver diseases with a protein MRI contrast agent Nat Commun 10 4777-169
[8]
Rockey DC(2017)Mechanisms of hepatic stellate cell activation Nat Rev Gastroenterol Hepatol 14 397-1349
[9]
Chen X(2020)[(18)F]-Alfatide PET imaging of integrin alphavbeta3 for the non-invasive quantification of liver fibrosis J Hepatol 73 161-512
[10]
Wen H(2018)Desmin- and vimentin-mediated hepatic stellate cell-targeting radiotracer (99m)Tc-GlcNAc-PEI for liver fibrosis imaging with SPECT Theranostics 8 1340-1437